193 related articles for article (PubMed ID: 11283930)
1. The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors.
Gerl A; Mühlbayer D; Hansmann G; Mraz W; Hiddemann W
Cancer; 2001 Apr; 91(7):1297-303. PubMed ID: 11283930
[TBL] [Abstract][Full Text] [Related]
2. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D
J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancer.
Brennemann W; Stoffel-Wagner B; Wichers M; Helmers A; Albers P; Mezger J; Klingmüller D
J Urol; 1998 Jun; 159(6):1942-6. PubMed ID: 9598493
[TBL] [Abstract][Full Text] [Related]
4. Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance.
Hansen SW; Berthelsen JG; von der Maase H
J Clin Oncol; 1990 Oct; 8(10):1695-8. PubMed ID: 1698935
[TBL] [Abstract][Full Text] [Related]
5. Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency.
Howell SJ; Radford JA; Ryder WD; Shalet SM
J Clin Oncol; 1999 May; 17(5):1493-8. PubMed ID: 10334536
[TBL] [Abstract][Full Text] [Related]
6. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
[TBL] [Abstract][Full Text] [Related]
7. Gonadal function after multimodality treatment in men with testicular germ cell cancer.
Palmieri G; Lotrecchiano G; Ricci G; Spiezia R; Lombardi G; Bianco AR; Torino G
Eur J Endocrinol; 1996 Apr; 134(4):431-6. PubMed ID: 8640293
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Daugaard G
Eur Urol Focus; 2018 Jul; 4(4):591-598. PubMed ID: 28753832
[TBL] [Abstract][Full Text] [Related]
9. Leydig cell function in patients with testicular cancer during and after chemotherapy.
Willemse PH; Sleijfer DT; Schraffordt Koops H; Pratt JJ; Sluiter WJ; Doorenbos H
Int J Androl; 1983 Dec; 6(6):497-508. PubMed ID: 6421750
[TBL] [Abstract][Full Text] [Related]
10. The pituitary-Leydig cell axis in men with severe damage to the germinal epithelium.
Tsatsoulis A; Whitehead E; St John J; Shalet SM; Robertson WR
Clin Endocrinol (Oxf); 1987 Dec; 27(6):683-9. PubMed ID: 3138051
[TBL] [Abstract][Full Text] [Related]
11. Preorchiectomy Leydig Cell Dysfunction in Patients With Testicular Cancer.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Gundgaard Kier MG; Mortensen MS; Daugaard G
Clin Genitourin Cancer; 2017 Feb; 15(1):e37-e43. PubMed ID: 27524512
[TBL] [Abstract][Full Text] [Related]
12. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
13. Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy.
Pectasides D; Pectasides M; Farmakis D; Nikolaou M; Koumpou M; Kostopoulou V; Mylonakis N
Eur Urol; 2004 Feb; 45(2):187-93. PubMed ID: 14734005
[TBL] [Abstract][Full Text] [Related]
14. Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.
Howell SJ; Radford JA; Adams JE; Smets EM; Warburton R; Shalet SM
Clin Endocrinol (Oxf); 2001 Sep; 55(3):315-24. PubMed ID: 11589674
[TBL] [Abstract][Full Text] [Related]
15. Reproductive toxicity with and without LHRHA administration during adjuvant chemotherapy in patients with germ cell tumors.
Kreuser ED; Hetzel WD; Hautmann R; Pfeiffer EF
Horm Metab Res; 1990 Sep; 22(9):494-8. PubMed ID: 1701752
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study.
Pozza C; Pofi R; Tenuta M; Tarsitano MG; Sbardella E; Fattorini G; Cantisani V; Lenzi A; Isidori AM; Gianfrilli D;
Hum Reprod; 2019 Aug; 34(8):1389-1403. PubMed ID: 31532522
[TBL] [Abstract][Full Text] [Related]
17. Leydig cell micronodules are a common finding in testicular biopsies from men with impaired spermatogenesis and are associated with decreased testosterone/LH ratio.
Holm M; Rajpert-De Meyts E; Andersson AM; Skakkebaek NE
J Pathol; 2003 Mar; 199(3):378-86. PubMed ID: 12579540
[TBL] [Abstract][Full Text] [Related]
18. Impaired testicular function in patients with carcinoma-in-situ of the testis.
Petersen PM; Giwercman A; Hansen SW; Berthelsen JG; Daugaard G; Rørth M; Skakkebaek NE
J Clin Oncol; 1999 Jan; 17(1):173-9. PubMed ID: 10458231
[TBL] [Abstract][Full Text] [Related]
19. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O;
Eur Urol; 2010 Jul; 58(1):134-40. PubMed ID: 20395037
[TBL] [Abstract][Full Text] [Related]
20. Gonadal function in patients with testicular germ cell tumors.
Tomomasa H; Oshio S; Ashizawa Y; Kamiyama Y; Okano Y; Iiyama T; Sato S; Shimizu H; Umeda T
Arch Androl; 2002; 48(6):405-15. PubMed ID: 12425758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
